Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jan;6(1):1-3.
doi: 10.1097/COH.0b013e328340ffa6.

Introduction: challenges to finding a cure for HIV infection

Affiliations
Review

Introduction: challenges to finding a cure for HIV infection

Douglas D Richman. Curr Opin HIV AIDS. 2011 Jan.

Abstract

Purpose of review: Renewed interest has emerged to address the latent reservoir of HIV to achieve a cure.

Recent findings: The integrated proviral genome is a fundamental component of the retroviral replication cycle. The establishment of latently infected CD4+ lymphocytes, and perhaps other as yet poorly characterized cells, represents a reservoir of HIV infection that is not appreciably affected by effective antiretroviral chemotherapy. Effective management of HIV infection, thus, will require lifelong treatment unless an approach to purging this reservoir is identified. Although substantial insights about the latent reservoir have been made, our understanding about the details of the reservoirs, the mechanisms of latency and potential targets to eliminate latently infected cells is too primitive to achieve a cure without a great deal of basic research to elucidate some of these areas.

Summary: A resurgence of interest in latent infection and its treatment promises progress in addressing the challenge of a cure, although, realistically, this will require a prolonged period of investigation in many areas.

PubMed Disclaimer

References

    1. Chun T-W, Carruth L, Finzi D, et al. Quantification of Latent Tissue Reservoirs and Total Body Viral Load in HIV-1 Infection. Nature. 1997;387:183–188. - PubMed
    1. Richman DD, Margolis DM, Delaney M, et al. The Challenge of Finding a Cure for HIV Infection. Science. 2009;23:1304–1307. Review of the state of the art in the field of HIV latency and a proposal to establish a collaborative program involving academia, industry and government to address the challenge. - PubMed
    1. Hermankova M, Ray SC, Ruff C, et al. HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination Therapy. JAMA. 2001;286:196–207. - PubMed
    1. Persaud D, Siberry GK, Ahonkhai A, et al. Continued Production of Drug-Sensitive Human Immunodeficiency Virus Type 1 in Children on Combination Antiretroviral Therapy Who Have Undetectable Viral Loads. J Virol. 2004;78:968–979. - PMC - PubMed
    1. Kieffer TL, Finucane MM, Nettles RE, et al. Genotypic Analysis of HIV-1 Drug Resistance at the Limit of Detection: Virus Production without Evolution in Treated Adults with Undetectable HIV Loads. JID. 2004;189:1452–1465. - PubMed

Substances